Sean McCutcheon
Stock Analyst at Raymond James
(3.97)
# 1,903
Out of 4,421 analysts
39
Total ratings
35.7%
Success rate
22.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean McCutcheon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RLAY Relay Therapeutics | Maintained: Buy | $19 → $26 | $15.88 | +63.73% | 2 | May 19, 2026 | |
| ENGN enGene Therapeutics | Maintained: Buy | $27 → $4 | $1.72 | +132.56% | 5 | May 8, 2026 | |
| CMPX Compass Therapeutics | Downgraded: Hold | n/a | $2.02 | - | 3 | Apr 28, 2026 | |
| VIR Vir Biotechnology | Maintained: Buy | $12 → $19 | $9.16 | +107.42% | 4 | Feb 24, 2026 | |
| BBOT BridgeBio Oncology Therapeutics | Initiated Coverage: Buy | $24 | $7.56 | +217.46% | 1 | Jan 9, 2026 | |
| RVMD Revolution Medicines | Maintained: Buy | $72 → $76 | $162.99 | -53.37% | 2 | Oct 17, 2025 | |
| BDTX Black Diamond Therapeutics | Maintained: Buy | $11 | $1.66 | +562.65% | 2 | Sep 10, 2025 | |
| RGNX REGENXBIO | Reiterated: Buy | $29 | $7.80 | +271.79% | 5 | Sep 5, 2025 | |
| XNCR Xencor | Maintained: Buy | $40 | $12.64 | +216.46% | 1 | Aug 7, 2025 | |
| LKFT Lakefront Biotherapeutics NV | Reiterated: Hold | n/a | $28.32 | - | 4 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $54.00 | - | 3 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $609.94 | - | 3 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $65 | $14.22 | +357.10% | 1 | Jul 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $86 | $27.93 | n/a | 3 | Jun 13, 2025 |
Relay Therapeutics
May 19, 2026
Maintained: Buy
Price Target: $19 → $26
Current: $15.88
Upside: +63.73%
enGene Therapeutics
May 8, 2026
Maintained: Buy
Price Target: $27 → $4
Current: $1.72
Upside: +132.56%
Compass Therapeutics
Apr 28, 2026
Downgraded: Hold
Price Target: n/a
Current: $2.02
Upside: -
Vir Biotechnology
Feb 24, 2026
Maintained: Buy
Price Target: $12 → $19
Current: $9.16
Upside: +107.42%
BridgeBio Oncology Therapeutics
Jan 9, 2026
Initiated Coverage: Buy
Price Target: $24
Current: $7.56
Upside: +217.46%
Revolution Medicines
Oct 17, 2025
Maintained: Buy
Price Target: $72 → $76
Current: $162.99
Upside: -53.37%
Black Diamond Therapeutics
Sep 10, 2025
Maintained: Buy
Price Target: $11
Current: $1.66
Upside: +562.65%
REGENXBIO
Sep 5, 2025
Reiterated: Buy
Price Target: $29
Current: $7.80
Upside: +271.79%
Xencor
Aug 7, 2025
Maintained: Buy
Price Target: $40
Current: $12.64
Upside: +216.46%
Lakefront Biotherapeutics NV
Jul 24, 2025
Reiterated: Hold
Price Target: n/a
Current: $28.32
Upside: -
Jul 17, 2025
Maintained: Hold
Price Target: n/a
Current: $54.00
Upside: -
Jul 17, 2025
Maintained: Hold
Price Target: n/a
Current: $609.94
Upside: -
Jul 11, 2025
Initiated Coverage: Buy
Price Target: $65
Current: $14.22
Upside: +357.10%
Jun 13, 2025
Maintained: Buy
Price Target: $86
Current: $27.93
Upside: n/a